PYCR1 is associated with papillary renal cell carcinoma progression

Wang Qiu-Li; Liu Ling

doi:10.1515/med-2019-0066

Open Medicine (Aug 2019)

PYCR1 is associated with papillary renal cell carcinoma progression

Wang Qiu-Li,
Liu Ling

Affiliations

Wang Qiu-Li: Department of Nephrology, Jining NO.1 People’s Hospital, Jining, 272100, Shandong, China
Liu Ling: Department of Nephrology, Jining NO.1 People’s Hospital , No.6 Jiankang Road, Jining, 272100, Shandong, China

DOI: https://doi.org/10.1515/med-2019-0066
Journal volume & issue: Vol. 14, no. 1
pp. 586 – 592

Abstract

Read online

We aimed to determine the function of pyrroline-5-carboxylate reductase 1 (PYCR1) on progression of papillary renal cell carcinoma (PRCC) and related mechanism.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords